1* B)¼ - Jichi · 2019-09-25 · 1* c+¬ &É ± Û+« Ë%Ê'2'¼ Ô#. B $ ( b 1 Z K S>&2018 º10 v9 ¥ +« ±18-070 >' 2.0[ ¨ 2.1. H* X í/ H"á b º N&ã 4# d24 G b ² \1 [ Ì

$Page 1: 1* B)¼ - Jichi · 2019-09-25 · 1* c+¬ &É ± Û+« Ë%Ê'2'¼ Ô#. B $ ( b 1 Z K S>&2018 º10 v9 ¥ +« ±18-070 >' 2.0[ ¨ 2.1. H* X í*/ H"á b º N&ã 4# d24 G b ² \1* [ Ì$
329-0498 3311-1

0285-44-61920285-44-7217

2019 9

－1－

25

1970 2 1 24 1-43

2017 2018 2 25

IG IGIG IG

25 1

1.

25 100100 2017 1 1 2018 12 31 2

241,816

http://www.kawasaki-disease.net/kawasakidata/

2018 10 918-070

2.

2.1.24 2018 12 31

395,238 228,107 167,131 2017 20182017 15,164 8,635 6,529 2018 17,364 9,964 7,400

0-4 10 2017 313.6 348.9 276.5 2018 359.1 402.6313.4 2018 2015 330.2

2.2.

2015 9-10 20151 2016 6-710-11 2016 1

2.3.25 3,785

2,424 2,276 126131 151

－2－

2017 422.2 388.9 385.72018 495.7 436.0 434.62017 134.9 166.7 187 2018 158.1 202.4

252.2 2017 2018

2.4.25,661 78.9% 565 1.7% 6,289

19.3%

2.5.1,604 4.9% 1,042 5.6% 562 4.0%

11 0.03% 117 0.36%1,248 3.84% 2 0.01% 0 0% 283 0.87%

2,901 8.9% 1,850 9.9% 1,051 7.5%35 0.11% 309 0.95%

2,120 6.52% 6 0.02% 4 0.01% 503 1.55%

845 2.6% 548 2.9% 297 2.1%36 0.11% 206 0.63% 488

1.50% 6 0.02% 1 0.003% 164 0.50%

2.6.IG 30,784 94.6% IG 6,06119.7% IG 4,076 13.2%

IG 30,042 97.7% IG 11900-2099mg/kg 29,443 95.7% 900-1099mg/kg

754 2.45% 1 30,141 98.0% 2 5961.94% IG 5 10,710 34.8%

2.7.1 14,156 43.5%

8,465 3,187 758

2.8.696 2.1% 386 2.1% 310 2.2%

419 1.3%

214 51.1% 199 47.5%

3.

3.1.1,816 12 1,804

1,357 75.2Excel 139

27

－3－

1,357 924 68.165.2 95.5

3.2.1

24 2018 12 31 395,238228,107 167,131 2017 2018 2017

15,164 8,635 6,529 2018 17,364 9,964 7,400

2 2,8741 1,900

944956

20-4 10 2017 313.6 348.9 276.5 2018 359.1 402.6

313.4 2018 2015 330.2

2018 / 1.35 1.28

1 1979 1982 1986 31995 2010 12,000

1986 3 2012 1979 12 2013 15,000 1982 2

2016 2017 2018

2 2018 359.1402.6 313.4

3.3.3

2015 9-102015 1 2016 6-7

10-11 2016 12015 2016 1

2013 2018 2 94

3.4.25 2017 2018 2 25

4 71% 109-11 2017 472.2 2018 502.2

24 9-11 24 255

－4－

3.5.0-4 10 3 25

3,7852,424 2,276 126

131 1512017 422.2 388.9 385.7

2018 495.7 436.0 434.62017 134.9 166.7 187 2018 158.1 202.4

252.22017 2018

6 2015 20182018

3.6.25,661 78.9% 565 1.7% 6,289

19.3% 4 4 4,45970.9% 3 23.4% 2 5.1 %

5A 5 2002 2

17 5 65 B 4

3.7.1,478 4.5% 868 4.7% 610 4.4%

1

3.8.2017 2018 6 3 3 6 9

2 1 31 6

3.9.1 1

31,604 4.9% 1,042 5.6% 562 4.0%

11 0.03% 117 0.36%1,248 3.84% 2 0.01% 0 0% 283 0.87%

22,901 8.9% 1,850 9.9% 1,051 7.5%

35 0.11% 309 0.95%2,120 6.52% 6 0.02% 4 0.01% 503 1.55%

2845 2.6% 548 2.9% 297 2.1%

36 0.11% 206 0.63% 488 1.50%6 0.02% 1 0.003% 164 0.50%

－5－

2

3.52.6

27

U 715 1997-1998 20.1%

8

3.10.4 8,192 25.2% 20,679 63.6% 4

2 2 2 67.8% 42 60.3%

IG 5 10,710 34.8% 2 22 75.4% 5 2 67.4%

2 IG 8

3.11.IG 30,784 94.6% 17,608 94.7% 13,17694.6% 9 IG 6,061 19.7%

10IG 4,076 13.2%

3,463 13.8% 6712.7% 546 10.4%

699 17.1%3,447 84.6% 1

1011

IG 30,042 97.7%12 IG 1 1900-2099mg/kg

29,443 95.7% 900-1099mg/kg 754 2.45% 130,141 98.0% 2 596 1.94% 13 IG 1

1900-2099mg/kg 97.1%2100mg/kg+ 1.26% 900-1099mg/kg 0.85% 2000mg/kg

IG 9 9

3.12.IG IG 21.6% IG

2 2 2

IG 6.28% 22 2

IG 2.57%2 2 2

1.4%IG 1.46% 2

2IG 0.53% 2

－6－

2 2 14IG

IG IG 91.1% 22 2

IG 24.8% 22

IG 12.1%2 2 2

IG 6.5% 22 2

IG 2.6% 22 2 15

3.13.1 14,156 43.5%

8,060 43.3% 6,096 43.8%

168,465 3,187

758 17

3.14.696 2.1% 386 2.1% 310 2.2%

419 1.3%18

214 51.1% 199 47.5% 19

3.15.1,706 5.2% 1,075 5.8%

631 4.5% 10

20

4.

1

http://www.jichi.ac.jp/dph/inprogress/kawasaki/

－7－

5.

1971.1975; 22 6 : 306-312.

1975; 5 12 : 22-29.1976; 34 2 : 275-283.

-1979; 20 7 : 755-757.

1981;22 1 : 53-58.

-1983; 24 1 : 53-58.

1985; 26 9 : 1049-1053.

1986; 37-51.1987; 28 9 : 1059-1066.

1988; 18-31.1990; 31 5 : 569-576.1992; 33 3 : 309-316.1994; 35 1 : 61-73.1996; 37 4 : 363-383.

1998; 61 3 : 406-420.2000; 63 1 : 121-132.2002; 65 2 : 332-342.

2002.2004; 67 2 : 313-323.2006; 69 2 : 281-292.

1989 20042007; 111 6 : 740-745.

2008; 71 2 : 349-360.20

2010; 73 1 : 143-156.21

2012; 75 3 : 507-523.22

2014; 77 2 : 271-290.23

2016; 79 2 : 273-292.24

2018; 81 2 : 271-274.Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrilemucocutaneous lymph node syndrome MLNS prevailing in Japan. Pediatrics 1974; 54: 271-276.Yanagawa H, Kawasaki T, Shigematsu I. Nationwide survey on Kawasaki disease in Japan. Pediatrics1987; 80: 58-62.Yanagawa H, Nakamura Y, Yashiro M, Fujita Y, Nagai M, Kawasaki T, Aso S, Imada Y, ShigematsuI. A nationwide survey of Kawasaki disease in 1985-1986 in Japan. J Infect Dis 1988; 158 6 :1296-1301.Yanagawa H, Yashiro M, Nakamura Y, Kawasaki T, Kato H. Epidemiologic pictures of Kawasakidisease in Japan: From the nationwide survey in 1991 and 1992. Pediatrics 1995; 95 4 : 475-479.

－8－

Yanagawa H, Yashiro M, Nakamura Y, Kawasaki T, Kato H. Results of 12 nationwideepidemiological incidence surveys of Kawasaki disease in Japan. Arch Pediatr Adolesc Med1995; 149: 779-783.Yanagawa H, Nakamura Y, Yashiro M, Ojima T, Koyanagi H, Kawasaki T. Update of theepidemiology of Kawasaki disease in Japan, From the results of 1993-94 nationwide survey. JEpidemiol 1996; 6 3 : 148-157.Yanagawa H, Nakamura Y, Yashiro M, Ojima T, Tanihara S, Oki I, Zhang T. Results of thenationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan. Pediatrics 1998;102 6 : e65.Yanagawa H, Nakamura Y, Yashiro M, Oki I, Hirata S, Zhang T, Kawasaki T. Incidence survey ofKawasaki disease in 1997 and 1998 in Japan. Pediatrics 2001; 107 3 : e33.Nakamura Y, Yashiro M, Uehara R, Oki I, Watanabe M, Yanagawa H. Epidemiologic Featuresof Kawasaki Disease in Japan:Results from Nationwide Survey in 2005-2006. J Epidemiol2008; 18(4): 167-172.Nakamura Y, Yashiro M, Uehara R, Oki I, Watanabe M, Yanagawa H. Monthly observation of thenumbers of patients and incidence rates of Kawasaki disease in Japan: results from nationwidesurveys. J Epidemiol 2008; 18(6): 273-279.Nakamura Y, Yashiro M, Uehara R, Sadakane A, Chihara I, Aoyama Y, Kotani K, Yanagawa H.Epidemiologic features of Kawasaki disease in Japan: Results of the 2007-2008 nationwide survey.J Epidemiol 2010; 20(4): 302-307.Nakamura Y, Yashiro M, Uehara R, Sadakane A, Tsuboi S, Aoyama Y, Kotani K, Tsogzolbaatar EO,Yanagawa H. Epidemiologic features of Kawasaki disease in Japan: Results of the 2009-2010nationwide survey. J Epidemiol 2012; 22(2): 216-221.Makino N, Nakamura Y, Yashiro M, Ae R, Tsuboi S, Aoyama Y, Kojo K, Uehara R, Kotani K,Yanagawa H: Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results ofthe 22nd nationwide survey. J Epidemiol 2015; 25 3 :239-245.Makino N, Nakamura Y, Yashiro Mayum, Sano T, Ae R, Kosami K, Kojo T, Aoyama Y, Kotani,K, Yanagawa H. Epidemiological observation of Kawasaki disease in Japan,2013-2014. PediatricsInternational 2018; 60:581-587.Makino N, Nakamura Y, Yashiro M, Kosami K, Matsubara Y, Ae R, Aoyama Y, Yanagawa H.Nationwide epidemiologic survey of Kawasaki disease in Japan,2015–2016. Pediatrics International2019; 61:397-403.

34 37-41 Journal of Epidemiology http://www.jstage.jst.go.jp/article/jea/35 36 Pediatrics http://www.pediatrics.org/cgi/content/

－9－

－10－

－11－

－12－

－13－

－14－

－15－

－16－

－17－

－18－

－19－

－20－

－21－

196.1176.8

359.1

78.0

215.8

175.4194.7

157.9

402.6

313.4

88.1

67.3

2018

19821986

1979

－22－

－23－

－24－

－25－

－26－

NTT

JAJAJAJAJAJCHO

KKR

－27－

JA

JCHO

10

11

JCHO

TMG

12

13

NTTJR

－28－

14

AOI

15

JA

16

JCHO

17

JCHO

－29－

18

JCHO

19

20

21

JA

22

JAJA

23

AOI

JCHO

－30－

24

JCHO

25

26

27

JCHO

28

JCHO

－31－

29

30

31

32

33

34

JR

35

JCHO

36

37

38

－32－

39

40

41

42

-

43

44

45

46

47

－33－

[email protected]

Documents

1* B)¼ - Jichi · 2019-09-25 · 1* c+¬ &É ± Û+« Ë%Ê'2'¼ Ô#. B $ ( b 1 Z K S>&2018 º10 v9 ¥ +« ±18-070 >' 2.0[ ¨ 2.1. H* X í*/ H"á b º N&ã 4# d24 G b ² \1* [ Ì

1* B)¼ - Jichi · 2019-09-25 · 1* c+¬ &É ± Û+« Ë%Ê'2'¼ Ô#. B $ ( b 1 Z K S>&2018 º10 v9 ¥ +« ±18-070 >' 2.0[ ¨ 2.1. H* X í/ H"á b º N&ã 4# d24 G b ² \1 [ Ì